device designed to make it easier for individuals with Obstructive Sleep Apnea (OSA) to start and stay on therapy. “The ResMed 2024 Global Sleep Survey, conducted across 17 markets worldwide ...

Philips’ (NYSE:PHG) decision to halt sales of its respiratory care devices in the U.S. to meet regulatory requirements is likely favorable to its rival, ResMed ... recall of sleep apnea and ...

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...

This can lead to some large bumps in the road, as ResMed just discovered ... The Phase III study assessed the efficacy and safety of tirzepatide — a 'GLP-1' drug that causes weight loss — in treating ...

Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...